Zobrazeno 1 - 10
of 98
pro vyhledávání: '"L, Busutti"'
Autor:
Ettore C. degli Uberti, Fiorenza Bertelli, Lewis E. Braverman, Roberta Elisa Rossi, Elio Roti, Elizabeth N. Pearce, L. Busutti, Maria Rosaria Ambrosio, Giorgio Trasforini
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 91:2171-2178
The recognition of thyroid microcarcinoma has increased due to the widespread use of ultrasound-guided fine-needle aspiration biopsies.The objective of this study was to describe histological and clinical characteristics of papillary thyroid microcar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d18dfec0622d56421879c795571eecf7
https://doi.org/10.1210/jc.2005-2372
https://doi.org/10.1210/jc.2005-2372
Publikováno v:
Radiotherapy and Oncology. 115:S887-S888
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae3de6dd39eee758de6a1adea3cde1ea
https://doi.org/10.1016/s0167-8140(15)41611-1
https://doi.org/10.1016/s0167-8140(15)41611-1
Autor:
L, Fuccio, A, Guido, L, Laterza, L H, Eusebi, L, Busutti, F, Bunkheila, E, Barbieri, F, Bazzoli
BACKGROUND: Radiotherapy is an established treatment modality for prostate cancer; however, up to a third of patients develops a radiation-induced proctopathy. AIM: To assess the effect of topical beclomethasone dipropionate (BDP) in the prevention o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::a3844d116817080be87c6cfa6dc56f35
http://hdl.handle.net/11585/113891
http://hdl.handle.net/11585/113891
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 22:585-588
Thirty-four patients affected by primary pulmonary carcinoma or in a state of recurrence after surgery were analyzed and 2g/M 2 of etanidazole was administered intravenously. After 30 min (group A), 60 min (group B), and 120 min (group C), both the b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc54fb640aa2d6719a1f8bdd1ac4ad73
https://doi.org/10.1016/0360-3016(92)90882-i
https://doi.org/10.1016/0360-3016(92)90882-i
Autor:
Maria Chiara Zatelli, Lewis E. Braverman, Alessia David, Roberta Elisa Rossi, Elio Roti, Annabella Blotta, L. Busutti, Ettore C. degli Uberti, Marta Bondanelli
Publikováno v:
Thyroid : official journal of the American Thyroid Association. 15(2)
In the present study we examined the clinical value of a differential response of thyroglobulin (Tg) concentration after recombinant human thyrotropin (rhTSH) stimulation (rhTSH Tg testing) and its correlation with (131)I uptake and whole-body scanni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d38b87de20fd2ece72054d8638c3daf
https://pubmed.ncbi.nlm.nih.gov/16756477
https://pubmed.ncbi.nlm.nih.gov/16756477
Autor:
L, Busutti
Publikováno v:
Minerva endocrinologica. 26(4)
Microcytoma (SCLC) is generally regarded as a disease requiring chemotherapy and is only treated with radiotherapy using combined protocols. A number of different approaches have been proposed, changing timing, dose and fractionation. A different rol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cb76b601c81ea6f603fe34f8c80ccf82
https://pubmed.ncbi.nlm.nih.gov/11782711
https://pubmed.ncbi.nlm.nih.gov/11782711
Autor:
Stefano Boriani, Caterina De Vinci, Giuseppe L. O. Conte, Ennio Dragoni, Tiziano Bergami, L. Busutti, Vittorio Fornarola, Rodolfo Capanna, G. Pizza, Ernesto Aiello, Paolo Maver, A. Palareti
Publikováno v:
International journal of cancer. 94(1)
From April 1986 to September 2000, 122 MRCC patients were treated by monthly intralymphatic injections (containing a mean of 573 IL-2 U and 26 × 106 LAK cells) and i.m. administration of IFN and TF; 71 patients also received a 3-day cycle of monthly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e04efdb72ff96a9f37952cbbcccf2c9
https://pubmed.ncbi.nlm.nih.gov/11668485
https://pubmed.ncbi.nlm.nih.gov/11668485
Autor:
A, David, A, Blotta, M, Bondanelli, R, Rossi, E, Roti, L E, Braverman, L, Busutti, E C, degli Uberti
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 42(10)
The use of recombinant human thyroid-stimulating hormone (rhTSH) has recently become available as an alternative diagnostic tool to assess the persistence and recurrence of differentiated thyroid carcinoma (DTC) in patients on thyroid hormone-suppres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b83faa077f0e27734002569b3869d3a5
https://pubmed.ncbi.nlm.nih.gov/11585859
https://pubmed.ncbi.nlm.nih.gov/11585859
Publikováno v:
Annals of Oncology. 3:864-866
Summary Thirty-seven patients with unresectable NSCLC received epirubicin (EPI) as i.v. bolus at the dose of 120 mg/sm + cisplatinum (CP) at the dose of 60 mg/sm every 28 days up to the maximum cumulative dose of 840 mg/sm of EPI. Of 35 evaluable pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40409936d8e1918582f8ea20d8cb2f87
https://doi.org/10.1093/oxfordjournals.annonc.a058114
https://doi.org/10.1093/oxfordjournals.annonc.a058114
Publikováno v:
La Clinica terapeutica. 150(2)
To compare the results, in terms of 10-year actuarial survival, between I-131-therapy and I-131-therapy + external beam radiotherapy (RT) in patients operated on for differentiated thyroid carcinoma.Over a period of 13 years (1982-1995) 408 patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d1ccc4145cb2fde792ba91d8b0d79aa3
https://pubmed.ncbi.nlm.nih.gov/10396858
https://pubmed.ncbi.nlm.nih.gov/10396858